No elevated risk for osteoporosis or osteopenia among women with androgenetic or frontal fribrosing alopecia treated with 5-alpha reductase inhibitors: A retrospective TriNetX cohort study

View at publisher
Authors: Daniela Mendez, Marc A. Hill, Melissa Peck Piliang, Wilma Bergfeld
Cited by: 0
References: 2

Fields of Study & Subjects

Hair Growth and Disorders Folate and B Vitamins Research Fibromyalgia and Chronic Fatigue Syndrome Research

Publication details

Journal / source
Journal of the American Academy of Dermatology
Volume
94
Issue
4
Pages
1340–1342
Publication date
7 January 2026
Language
EN